Altimmune Inc

NASDAQ:ALT  
15.97
+0.11 (+0.69%)
Other Pre-Announcement

Altimmune Posts Q1 Loss Per Share $0.38

Published: 05/17/2021 11:16 GMT
Altimmune Inc (ALT) - Altimmune Announces First Quarter 2021 Financial Results and Provides a Corporate Update.
Q1 Loss per Share $0.38.
Q1 Revenue $800,000.
Q1 Revenue Estimate $2.1 Million -- Refinitiv Ibes Data (analyst estimates).
Q1 Earnings per Share Estimate $-0.47 -- Refinitiv Ibes Data (analyst estimates).
Data Readouts From Phase 1 Adcovid and Alt-801 Clinical Trials Expected in June 2021.
Cash, Cash Equivalents and Short-term Investments Totaling $226.5 Million at March 31, 2021 Compared to $216.0 Million at December 31, 2020.